written by reader Thoughts from Myron — A Historic American Treasure

by takeprofits | March 6, 2014 8:40 am

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://www.stockgumshoe.com/2014/03/microblog-thoughts-from-myron-a-historic-american-treasure/


36 responses to “written by reader Thoughts from Myron — A Historic American Treasure”

  1. alriner says:

    I’m new here but here’s my answers to your quiz.
    1. $5,000
    I’m betting many of us have a far ranging amount of funds available to invest. While $5,000 may be a lot for some investors here, for others it may only be a drop in the bucket. Considering a percentage of an investors funds to risk under this question may be better than a $ figure. Just my $0.02.

    2. All things being equal, I’d spread the risk over the 5 positions.
    3. I’d invest in stocks where the fundamentals show great potential rather than chase one hitting new highs. I may have to sit on it longer but chances are, it’s just a matter of time before the market realizes the value of a stock with great potential.

  2. ryansch says:

    Myron, as a fellow Canadian, I’m wondering what method you use to buy USD for investment in US-listed stocks? Do you use the ‘norbert’s gambit’ method, pay the 1-2% brokerage currency exchange commission, or have another, better way? Can you enlighten your fellow Canadians? Thanks for everything. If anyone else has suggestions for Canadian investors, please speak up! Ryan

  3. Jeb seems like a nice guy and I think LODE has great potential. But it is probably worth mentioning that he is PAID to promote Comstock Mining. They are a sponsor of his website and newsletter, so his view is not exactly unbiased and objective. He might not be paid by a big publishing company, but it is a little misleading to suggest he is independent or unbiased in regards to his stock picks. I prefer analysts that are not compensated by the companies they are writing about. The conflict of interest is glaring.

  4. Dennis says:

    1. $5k
    2. 5 stocks unless one has a compelling value proposition to go all in.
    3. Potential over 52 week highs that don’t seem to mean much anymore.

    I would like to see more information and updates of specific stocks that are developing software, etc in the cyber attack sector. I realize some have been mentioned on this site but new companies continue to evolve. My portfolio consists of 40% biotechs / healthcare, 15% financials; 20% energy and the rest in technology. Hope this helps and perhaps this will get favorable comments from irregulars.

  5. hgpark888 says:

    Hello Myron,
    What do you think about your past stock recommendation:
    MUN: haven’t been performing that will. It seems like it’s on moving trend somewhat..
    VTI: Did you end up buying more of the share?
    BXE: bumped up nicely today over the material reserve increase.

    One thing I have trouble trading stocks is I can’t seem to find a right time to sell.
    I’ve posted a post on discussion section, but nobody really gave any input.
    What triggers your sell position?

  6. notaguru says:

    Hi Myron,
    Thanks for giving all the detailed information. I appreciate it a lot.
    Answers:
    1) $5,000
    2) Spread it across 5 stocks
    3) Good fundamentals
    I’m extremely happy with the past info you gave about ANV, AVPMF, BALMF, BRIZF, GLBXF, LRSEF, MGPHF, UEC, URZ & UUUU.
    Until I started reading Stock Gumshoe, I had that terrible habit of “keeping the dogs and selling the winners”. Thankfully, that’s behind me. However, I have a different problem: how do I decide which of the winners to sell in order to buy the companies that are very good buys now (hopefully before their run)? I’m in the same boat as the previous poster John Park.

  7. hipockets says:

    Thank you for your column, Myron, and for the work that you put into it. I learn something from each column.

    My answers to your questions –

    1 – Would not the answer to this question depend on one’ resources? I have 10 % of my resources in speculative stocks. I maintain the 10 % as the portfolio grows. So far I have not adjusted the percentage when the portfolio total dips.

    2. For me, splitting the speculatives into several stocks is best. I try for the “maximum possible result”, rather than the “maximum result possible”. Or, paraphrasing a Gumshoe member from another article, “I swing for the bases, not for the fence”.

    The 10 % basket holds 20 stocks. I used my “judgment”, such as it is, for determining the number of shares (ranging from 200 to 2500) and the purchase price (from $0.15 to $2.60) for each stock. The speculation basket is up 19 % (over 8 months, since I started reading your column) , and the core stock basket is up 26 % (over 14 months). A third basket, the miscellaneous one, is up 15 % (over 2 years). (Curses upon thee, CSCO, QIHU, FTR, SCMR, and Kramer !! )

    3. I’m not a momentum player – and I’m still learning about fundamentals. I have based my purchases on hours and hours of reading.

    After reading the above prior to posting, it strikes me that 20 speculative stocks is too many. I should try for a few doubles instead of a bunch of singles. I will work on this as I develop more confidence in my research and judgment .

    Thanks again!

  8. ericsarmy says:

    Hey Myron,
    Sicne you’re the “go to” guy for micro cap mining stocks I was wondering what your opinion was on Falco Pacific Resource Group? Thanks.

  9. tompaol says:

    Thank you Myron for genuine insight.
    In answer to your question.
    $5000
    Invested in five stocks
    Stocks that show good potential (after reading your homework assignment but not started it yet I am questioning if this is the right approach).
    for instance I replied on your last newsletter on UUUU and UEC and a couple of others. I went back into UEC after selling for a loss and have made that back + some. I was able to get into URZ and am up there, as well as adding to Denninson Mines. I continue to watch UUUU go up without an entry and still wonder “do or don’t I” as it continues to make new 52 week highs.
    I am quite happy with your suggestions and my success with the other stocks you mentioned and look forward to your newsletters. Now off to do my homework.
    Thank you

  10. nicholda says:

    Hi Myron! I visited Your Website. It seems as though there
    haven’t been any updates since September 2012?!? Am I
    mistaken? Please advise with thanks…

  11. poppajohn says:

    Well, your first question is hard for me to answer as my answer begins with a highly irresponsible number like !00% of my portfolio spread between two accounts is in high risk stocks. I am constantly seeding, weeding and harvesting so liquidity is an important issue and as mistakes expose themselves, I dump quickly. I also tend not to invest in anything except minerals and Energy. I also never chase a stock that I have missed the boat on. However I will add to stocks that I have a position in that reach new highs. That means the ones on your list that I own and am buying are (American Symbols) DNN and URZ. A third one which should have made the list but missed by a couple of pennies was FCUUF. All are uranium stocks. I also had UUUUU and dumped it for a small profit when they changed management and the stock had a severe drop overnight. Oh well we all have to do what we are comfortable with. I am up about 35% since January 1, mostly on picks I have selected from your picks and occasionally Travis. Right now I am mostly in cash as I don’t trust the market stability but cash does not produce a 35% return in two months so I know I have to get back in. I have also done well on my joke stocks which include ADHD, PHOT and a few more. As to the newcomers, my worst sin is still selling early. I have hit 100% several times but doubt I will never see a ten banger because I will take the sure profit on the first dip and seek another undervalued stock.

  12. cajungun13 says:

    PHOT get back in…

  13. hipockets says:

    Myron, only one of the five stocks you gave us to research is listed in the States by the ticker symbol you used. That stock is URZ, which I bought after your review, and is up 28 % since the purchase.

    However, in the States, MSL (Toronto) (Merus Labs International) is available on the NASDAQ as MSLI and is a specialty pharmaceutical company.

    According to its website ( http://www.meruslabs.com/ ):
    • It currently has only two products – one for treatment of urinary urgency and incontinence and one for treatment of C. difficile infection (CDI). It plans to grow by acquiring and licensing novel pharmaceutical products, and has an European subsidiary established to manage European product acquisitions.
    • The management team seems to have the right experience. [ What else could their website say? :>) ] Elie Farah, the CEO & President joined the company in 2010; Andrew Patient was appointed Chief Financial Officer in 2010. A Google search for Elie Farah leads one to Bloomberg Business Week, which lists his background in some detail. ( http://investing.businessweek.com/research/stocks/people/person.asp?personId=1084861&ticker=TTH:CN. )
    • For the year ended September 30, 2013, the Company incurred a net loss of $3,102,129 compared to a net loss of $20,720,548 for the year ended September 30, 2012. ( http://www.meruslabs.com/pr/merus/12.30.13.pdf ) It looks like the losses are going in the right direction.
    • For the three months ended December 31, 2013, the Company incurred a net loss of $1,885,761 compared to net earnings of $297,541for the three months ended December 31, 2012. ( http://www.meruslabs.com/pr/merus/2.13.14.pdf ). (Bummer, Dude !! ) I’m still trying to get my head around the $1.5 million difference. The company attributes it to, “Larger than expected orders placed in the last fiscal quarter of 2013 resulted in lower than normal Enablex® ordering and associated revenues in the first quarter of fiscal 2014. “

    According to MarketWatch.com there has been no insider trading, and the company is being followed by 4 analysts, all of whom have a “Buy” rating. The Average Target Price is $2.79.

    According to Scottrade, the market cap is $66 million, average trading is 3880 shares per day, and the P/E ratio is not meaningful.

    The stock was hovering around $1.00 in 2010. It climbed to over $2.00 in 2011 after Elie Farah, the CEO & President, joined the company, then to $2.50 in 2012, and then fell to $0.50 in the Spring of 2013. Since then it has meandered up to about $1.70, with most of the meandering taking place in the past month.

    I know very little about the pharmaceutical industry, but I like the niche this company is in and their plans for growing. I also like the facts that they already have two products that are doing well and that they have an European branch to help their growth there. And, of course, I like the four “Buy” recommendations.

    Would I invest in the company? I don’t think so. I did not see any catalyst that would spur their growth and there has been no recent news about the company. But I have put it on my watch list.

    By the way, I think that it is a positive that the recent growth has occurred without any news.

    O.K., GumShoe-ers and Gumshoe-esses, any thoughts for other ways to do “Due Diligence”?

  14. blufox says:

    Myron, we’re about the same age. Here are my responses:
    1- 5,000 2-split over 5, well researched equities 3- Fundamentals that show great potential
    This is how I currently invest. I have 2 decent sized portfolios with about 123 positions: 18 in agriculture, 27 in energy, 8 in base metals, 28 in precious metals which totals 81 positions. The balance is spread out in Banking/Finance, Biotech, Technology, and miscellaneous. /* Phil */

  15. arch1 says:

    Myron: Surefire method… 1. Buy stocks which go up 100% or more & sell before drop. 2. Don’t buy stocks which don’t go up 100%. I have some small difficulty in my execution of said rules.

  16. fatboy2281 says:

    Took a position in Comstock Mining (LODE) and it has fallen on it’s face in a 2 week period.
    Could your recommendation have been that far off or are we coming back?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.